In vivo effect of teicoplanin and vancomycin upon haemolytic and bactericidal activity of serum against Staphylococcus aureus

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 19, Issue 4, 1996, Pages 283-288

  Rodriguez A B ^a   Pedrera, M I ^a   Barriga, C ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Bactericidal activity; Complement system; Haemolytic activity; Serum; Teicoplanin; Vancomycin

Indexed keywords

BACTERICIDE; TEICOPLANIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; COLONY FORMING UNIT; COMPLEMENT SYSTEM; CONTROLLED STUDY; HEMOLYSIS; MALE; MONOCYTE; MOUSE; NONHUMAN; SERUM; SHEEP ERYTHROCYTE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALIA; OVIS ARIES; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0030249687     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0147-9571(96)00011-2     Document Type: Article

References (18)

1. 1. Pryka R. D., Rodvold D. A. and Rotscchafer J. C. Teicoplanin: an investigational glycopeptide antibiotic. Clin. Pharm. 7, 647-658 (1988).
2. 2. Williams A. H. and Gruneberg R. N. Teicoplanin. J. Antimicrob. Chemother. 22, 397-401 (1988).
3. 3. Barry A. L., Thornsberry C. and Jones R. N. Evaluation of teicoplanin and vancomycin disk susceptibility test. J. Clin. Microbiol. 23, 100-101 (1986).
4. 4. Cynamon M. H. and Granato P. A. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Antimicrob. Agents. Chemother. 21, 504-505 (1982).
5. 5. Carper H. T., Sullivan G. W. and Mandell G. L. Teicoplanin, vancomycin, rifampicin: in vivo and in vitro studies with Staphylococcus aureus. J. Antimicrob. Chemother. 119, 659-662 (1987).
6. 6. Figueroa J. E. and Densen P. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4, 359-395 (1991).
7. 7. Brown E. J. and Joiner K. A. Mechanisms of host resistance to bacterial infection. In Immunological Diseases (Edited by Samter M.), pp. 715-736. Little, Brown & Co., Boston (1988).
8. 8. Joiner K. A. Complement evasion by bacteria and parasites. Ann. Rev. Microbiol. 42, 201-230 (1988).
9. 9. Joiner K. A., Brown E. J. and Frank M. M. Complement and bacteria: chemistry and biology in host defense. Ann. Rev. Immunol. 2, 461-491 (1984).
10. 10. Barriga C., Muriel E., Benitez P. and De la Fuente M. Effect of Imipenem and Cefmetazole on CD2, Fc and CD3 lymphocyte receptor. Comp. Immunol. Microbiol. infect. Dis. 14, 297-302 (1991).
11. 11. Gaither T. and Frank M. Studies of complement-mediated membrane damage. The influence of erythrocyte storage on susceptibility to cytolysis. J. Immunol. 110, 483-489 (1973).
12. 12. Mayer M. M. Complement and Complement Fixation in Experimental Immunochemistry, 2nd edn (Edited by Kabat E. A.), pp. 133-240. Charles C. Thomad, Springfield, IL (1971).
13. 13. Pedrera M. I., Rodríguez A. B. and Barriga C. Teicoplanin, vancomycin: comparative study of their influence on the hemolytic and bactericidal activity of serum. Immunol. Infect. Dis. 4, 146-148 (1994).
14. 14. Gilbert D. N., Wood C. A., Bracis R. and Kimbrough R. C. Program abstract, 28th Intersci. Conf. Antimicrob. Agents Chemother., Oregon. Abstr. 935 (1988).
15. 15. Kaatz G. W., Seo S. M., Reddy V. N., Bailey E. M. and Rybak M. J. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 34, 2081-2085 (1990).
16. 16. Contrepois A., Joly V., Abel L., Pangon B., Vallois J. M. and Carbon C. The pharmacokinetics and extravascular diffusion of teicoplanin in rabbits and comparative efficacy with vancomycin in an experimental endocarditis model. J. Antimicrob. Chemother. 21, 621-631 (1988).
17. 17. Maple P. A. C., Hamilton-Miller J. M. T. and Brumfitt W. Comparative in vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin DuP 721 and DuP 105 against methicillin and gentamycin resistant Staphylococcus aureus. J. Antimicrob. Chemother. 23, 517-525 (1989).
18. 18. Fietta A., Mangiarotty P. and Gialdroni Grassi G. Chemotherapeutic agents: aspects of their activity on natural mechanisms of defense against infections. Therapy and toxicology. Int. J. Clin. Pharm. 21, 325-338 (1983).